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Ibuprofen is a non-steroidal anti-inflammatory drug that has a disadvantage in its oral use, such 
as gastrointestinal disorders, nausea, vomiting and gastric ulcers. Transdermal patch dosage forms are 
an alternative in overcoming this weakness. The transdermal patch is formulated using a special 
membrane that can control drug release in a matrix system. Therefore, this study optimizes chitosan 
and HPMC as polymers using a factorial design approach. The parameters tested included weight 
uniformity, patch thickness, swelling index, in vitro release rate, folding resistance, ibuprofen 
uniformity, surface pH, and moisture content. The interactions between the components were 
evaluated using Fourier transform infrared spectrophotometry-attenuated total reflectance (FTIR-
ATR). The optimum concentration of chitosan was 0.5% and HPMC 6% with CV values for weight 
uniformity of 0.003 ± 1.202%; humidity 0.543 ± 5.595%; swelling index 4.611 ± 23,657%; thickness 
0.052 ± 2.428%; surface pH 5; durability is less than 300 times and the uniformity of ibuprofen levels 
is 1.52 ± 2.99%. The design approach using the FFD22 obtained an effective and efficient 
mathematical-statistical model to determine the optimal polymer combination in the formula. As an 
additional instrument in design evaluation, the chemometric approach is constructive in modeling and 
optimization. 
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Ibuprofen has been widely used in therapy as an analgesic (Motov et al., 2020), anti-
inflammatory, antipyretic and reduces rheumatoid arthritis symptoms (Wang et al., 2020). This active 
substance can reduce the number of prostaglandins, inhibit cyclooxygenase-1 (COX-1), and inhibit 
cyclooxygenase-2 (COX-2) (Romero-Chávez et al., 2018). Tracing reports and publications to date, 
oral use causes side effects of gastric ulcers, gastrointestinal disorders, nausea, vomiting, headaches, 
and bleeding (Kumar et al., 2013). Based on the biopharmaceutical classification system (BCS), 
ibuprofen is classified in Class II (Darusman et al., 2021). Therefore, to overcome side effects, 
increase solubility, and improve its release, it can be formulated in the form of a transdermal. 
Most of the inflammatory diseases occur locally and close to the body's surface so that 
transdermal preparations are expected to have a direct pharmacological effect and have a fast action. 
One of the transdermal dosage forms that can be effectively used for drug delivery is a patch (Kumar 
et al., 2013). Transdermal patches come in a plaster-like dosage form that is applied to the skin. The 
patch matrix can deliver specific drug doses through the skin (transdermal) into the bloodstream. The 
patch matrix is formulated using a special membrane that can control drug release in the system. This 
delivery system can avoid first-pass drug metabolism, easy to stop use in case of toxic effects, 
provides a constant drug concentration, reduces drug side effects indigestion, and maintains the 
bioavailability of drugs in plasma. Patches are also more able to guarantee dosage accuracy than gel or 
ointment preparations (Santos et al., 2018). 
The patch matrix has a patch type with minimal membrane leakage so that large amounts of 
drug release do not occur (Tyagi and Goyal, 2017). A critical component of the patch matrix for 
regulating the release rate is a polymer. Chitosan and HPMC were chosen because the hydrophobic 
and hydrophilic properties of each polymer strongly support drug release. Combining the two 
polymers aims to obtain a more effective drug release. Chitosan is hydrophobic, has antimicrobial 
activity, and is quickly processed in various products. Chitosan also has good stability and low toxicity 
(Pratiwi et al., 2019). HPMC is hydrophilic, easily hydrated by water, so it expands easily and 
accelerates drug release. The use of HPMC polymers without a rate regulating membrane will release 
the drug rapidly. Therefore, it is very interesting to combine it with chitosan. 
The optimum composition of the chitosan-HPMC combination in the patch matrix formulation 
can be designed using a factorial approach. Designs were evaluated using chemometric analysis to 
determine the pattern of proximity and correlation of defined responses (Shiyan et al., 2020). The 
combination of this multivariate analysis provides more information in the optimization procedure. 
Finally, the design of experiment (DoE) and multivariate analysis using chemometrics can obtain the 
optimal formula for the ibuprofen patch with chitosan and HPMC constituent polymers in the 
transdermal drug delivery system (TDDS) effectively and efficiently.  
MATERIALS AND METHOD 
Materials 
Ibuprofen was obtained from PT. Phapros (Semarang, Indonesia) and chitosan were purchased 
from PT Multiguna (Indonesia). Materials such as HPMC, propylene glycol, polyethyleneglycol 400 
were purchased from Bratachem (Jakarta, Indonesia).  
 
Optimization using Full Factorial Design (FFD) 
The combination of chitosan and HPMC polymers in the patch formulation was designed using 
a FD22 approach. The number of trial runs is determined using the Design-Expert software. The 
independent factor used is chitosan (A) with a level of 0.5-1% and HPMC (B) with 2-6%. The 
responses used for optimization evaluation on FFD 22 consist of weight uniformity (R1), moisture 
content (R2), swelling index (R3), and thickness (R4). The complete experimental design and results are 
shown in Table 1. 
 
                ISSN: 2088 4559; e-ISSN: 2477 0256 






Table 1. Full Factorial design 22 and complete formula of ibuprofen patch-transdermal 
Ingradient Function Formula 
  Run 1 Run 2 Run 3 Run 4 
A: Chitosan (%) Polymer 0.50 0.50 1.00 1.00 
B: HPMC (%) Polymer 6.00 2.00 2.00 6.00 
Ibuprofen (mg) Active substance 25.00 25.00 25.00 25.00 
PG (%) Enhancer 10.00 10.00 10.00 10.00 
PEG 400 (%) Plasticizer 20.00 20.00 20.00 20.00 
Responses (%CV)     
R1: Weight uniformity 2.28 2.08 2.09 2.30 
R2: Moisture content 9.03 12.66 11.96 20.54 
R3: Swelling index 23.75 26.28 27.02 24.15 
R4: Thickness 4.20 4.79 5.98 2.98 
 
Patch preparation 
Chitosan stock solution was prepared by dissolving 1 g in 100 mL of 1% acetic acid. A total of 
10 g of HPMC powder was dissolved with 100 mL of distilled water. Each was diluted as needed in 
the experimental design. Chitosan solution with a concentration according to Table 1 was poured into 
a beaker and stirred continuously during the magnetic film making process. Furthermore, 25 mg of 
ibuprofen was added to the mixture. PEG 400 as a plasticizer and propylene glycol as an enhancer was 
added. The mixture was poured into a petri dish with a diameter of 5.5 cm (after the bubbles were 
removed) and put in an oven at 60 ºC for 40 hours. Then the film preparations were stored in an 
airtight container and filled with silica for 4 days (constant weight was achieved). Visually dry patches 
with a surface that does not appear to be moist and evenly dry are removed from the cup. 
Determination of weight uniformity 
The weight uniformity test was carried out following Patel et al. (2012) with slight 
modifications. A total of ten matrices that have been cut with a size of 1 x 1 cm each were weighed. 
Test evaluation is based on the calculation of the coefficient variation (CV; %) of the number of 
matrices weighed. 
Determination of  moisture content 
The moisture content test was conducted to determine the amount of water content in the patch 
preparation, which could affect the stability of the preparation. Each patch measuring 1 x 1 cm that has 
been prepared is weighed and stored in a desiccator containing silica gel at 30 C for 24 hours. The 
patches are then weighed again (final weight). 
Determination of  swelling index 
The patch matrix with a size of 1 x 1 cm was put into a petri dish containing a phosphate buffer 
at a pH of 6.8. At specific minutes (5, 15, 30 and 60) the patch matrix was taken, and the remaining 
liquid on the surface was absorbed with filter paper before weighing (Singh and Prajapati, 2017).  
Determination of  patch thickness 
The thickness of the patch matrix is targeted to be no more than 1.0 mm—thickness test by 
measuring a patch matrix at four different points. The mean, standard deviation and coefficient 
variation were calculated to determine the thickness for each patch (Patel et al., 2012). 
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Determination of folding endurance 
The folding endurance is carried out by folding the matrix at the same point repeatedly until it 
breaks (Patel et al., 2012). The patch matrix in this test has a size of 1x1 cm. The patch matrix is 
classified as useful with a folding endurance value of more than 300 times. 
 
In vitro drug release assay 
The in vitro release of ibuprofen was carried out using a modified vertical type Franz diffusion 
cell. The donor section contains a patch matrix with a size of 1 x 1 cm and ibuprofen 25 mg.  
Separation of the donor and acceptor compartments using a cellophane membrane. A cut of the 
membrane according to the size of the diffusion cell is placed between the donor and acceptor 
compartments with the dermis side facing the acceptor compartment. The acceptor compartment 
contains 15 mL of phosphate buffer pH 7.4 and stirred with a magnetic stirrer at 600 rpm at 37 ± 0.5 
˚C (Ramkanth et al., 2015). Observations were made for 3 hours, and samples were taken at 5, 10, 20, 
30, 60, 90, 120, 180 minutes for each time taking 1 mL of samples.  Each sampling was replaced with 
1 mL of the same phosphate buffer solution in the assay. The absorption is measured at the maximum 
absorption wavelength and can be determined the amount of drug that is penetrated. 
Spectra FTIR-ATR  
Spectra patterns from Fourier transform infrared (FTIR-ATR) instrumentation can be used to 
study the physical and chemical interactions between drugs and additives (Pratiwi et al., 2019). The 
interaction between ibuprofen and the polymer was evaluated qualitatively by observing changes in 
peaks and shifts in specific wavenumbers. The readings of IR spectra were carried out on the pure 
components of ibuprofen, chitosan, HPMC, propylene glycol, PEG-400 and the formulated patch 
matrix. Each of the samples was placed in a holder and measured at a wavenumber of 4000-500 cm-1 
(Pratiwi et al., 2020; Sabati et al., 2017; Shiyan et al., 2018). 
 
Data Analysis 
The four runs of the experimental results according to the design were expressed as mean ± 
standard deviation (n=3). The data were analyzed and then obtained a contour plot of each response to 
the factor. The contour plot is combined into a contour plot superimposed/ overlay plot to determine 
the optimum composition of the combination of chitosan and HPMC to be used as the polymer. The 
approach uses principal component analysis (PCA) and cluster analysis (CA) to evaluate the degree of 
formula similarity and response correlation (Kartini et al., 2021; Shiyan et al., 2020). 
 
RESULT AND DISCUSSION 
Optimization using full factorial design 22 
The patch matrix is designed to regulate drug release, increase penetration so that it can be 
delivered to the circulatory system (Patel et al., 2012). The patch consists of two layers, and the first 
contains ibuprofen, a polymer, and other additives (namely matrices). The second layer is the backing 
as a diffusion barrier for ibuprofen and the direction of diffusion of the active substance (Singh and 
Prajapati, 2017). 
Figure 1 presents the results of the patch matrix of 4 runs or formulas. The matrix at run 1 
(chitosan 0.5% and HPMC 6%) produced good physical characteristics (Table 1; Figure 1A). The 
formulations in run 2 (chitosan 0.5% and HPMC 2%) have softer properties due to the lower 
construction of each polymer (Figure 1B). Run 3 at Figure 1C formulation produces a patch matrix 
that is slightly stiff due to the high concentration of chitosan. The formulation on the run four also 
produces stiff and rigid patches and uneven surfaces because each high concentration can increase the 
thickness of the solution before the printing process (Figure 1D). The results of research by Sarath et 
al. (2013) revealed that 0.5% chitosan provided the optimum patch. Therefore, the FD is used at a low 
level. Overall, from the statistical evaluation of the four models (R1, R2, R3 and R4), good modelling 
results are obtained to be used in determining the optimal prediction of polymer blends. Modelling 
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details related to the type of model, transformation status, and regression equation are presented in 
Table 3. Only in response 2 (moisture content) was transformed because the experimental data had not 
met the initial requirements so that the transformation had to be carried out. 
 
Figure 1. Transdermal patch matrix from FD design, (A) run 1, (B) run 2, (C) run 3, (D) 
run 4, (E) thickness measurement, (F) swelling index measurement with 3 
replicate from optimum formulas 
Tabel 2. Complete analysis of the evaluated responses in the FFD design optimization of polymer 












R1 2.19 0.01 0.51 0.001 0.9941 0.9911 0.9763 25.93 
R2 0.08 0.001 1.97 0.00 0.9987 0.9961 0.9792 45.16 
R3 25.30 0.42 1.66 1.42 0.9537 0.9306 0.8149 9.08 
R4 4.49 0.02 0.33 0.004 1.0000 0.9999 0.9992 230.94 
Note: R1 = weight uniformity; R2 = moisture content; R3= swelling index; R4 = thickness 
 
Table 3. Transformation status, model type and regression equation for each response 
Responses Transformation Model Regression equation 
R1 No Main effects R1 = 2.19 + 0.10B ………………(1) 
R2 Inverse Reduced 2FI R2  = 0.08 – 0.01A – 0.02AB ...…(2) 
R3 No Reduced main effects R3 = 25.30 – 1.35B ………….….(3) 
R4 No Reduced 2FI R4: = 4.49 – 0.90B – 0.60AB …...(4) 
Note: R1 = weight uniformity; R2 = moisture content; R3= swelling index; R4 = thickness 
 
Fitting model of weight uniformity response (R1) 
The predicted vs actual value of the weight uniformity is not too different with the difference 
between adjusted R2 and predicted R2 being less than 0.2. The model for R1 indicates that there is no 
significant difference between the observed data and the predicted data. Based on regression equation 
1 (Table 3), HPMC is more dominant in influencing the weight uniformity of the patch matrix. 
Chitosan is a polymer that can interact and absorb active compounds from the patch in a certain 
amount so that the HPMC-chitosan (AB) interaction will increase weight uniformity (Kulig et al., 
2017). The effect of the polymer on the weight uniformity parameters is highlighted on the contour 
plot and 3D surface plot (Figure 2A). The blue area indicates that the result is less than the red area. 
High HPMC concentrations and low chitosan concentrations can reduce the %CV response to weight 
uniformity (blue area). A low %CV value indicates excellent matrix weight uniformity. Systematically 
and scientifically, the FFD approach will provide a better interpretation. In theory, HPMC with high 
concentration and low level of chitosan obtained a low %CV weight uniformity. 
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Fitting model of moisture content response (R2) 
Based on equation 2 (Table 3), chitosan (A) and the interaction of chitosan-HPMC (AB) effect 
decreasing the CV value of moisture content. The interaction scheme in (Figure 2F) shows the 
concentrations of HPMC and chitosan with different constructions resulting in different moisture 
responses. The polymer effect on moisture was confirmed on the contour plot and 3D surface (Figure 
2B). The blue area indicates that the CV is worth less than the red area. High levels of HPMC and low 
levels of chitosan can reduce the response indicated by the blue area. 
 
Figure 2. Results of model analysis, (A) 3D surface plot of weight uniformity, (B) 3D surface plot 
of moisture content, (C) 3D surface plot of swelling index, (D) 3D surface plot of 
thickness, (E) interaction from weight uniformity response,  (F) interaction from 
moisture content response, (G) interaction from swelling index response, (H) 
interaction from thickness response 
Fitting model of swelling index response (R3) 
Chitosan can form hydrogen bonds intramolecularly and between molecules in its structure. An 
increase in the swelling index occurred at the 5th minute. Hydrophilic and hydrophobic polymers 
absorb water very quickly due to the empty cavity containing the solvent which diffuses into the patch 
and accelerates the dissolution of the gel. HPMC affects the increase in the swelling index (Table 3, 
Equation 3). The effect of the polymer on the swelling index is highlighted in contour plots and 3D 
surface plots (Figures 2C). 
Fitting model of thickness response (R4) 
The thickness of the matrix affects the physical properties and the folding resistance. Patch 
thickness is uniform with good test reproducibility. Model fittings show that the data are normally 
distributed and meet the requirements of statistical analysis. Based on equation 4 (Table 3), HPMC 
greatly affects the thickness of the matrix. 
Chemometrics analysis approach 
The chemometric approach is used to evaluate the design used in optimization. The results of 
the analysis indicate that the four formulas do not group. Each of them has different characters, which 
indicates that the early stages of modeling are going well. The FD design cannot easily explain the 
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correlation between responses, but the PCA results can be seen quickly by loading the plot. The 
complete results of the analysis using the PCA-CA technique are shown in Figure 3. 
 
Figure 3. (A) Score plot, (B) Dendrogram, (C) Loading plot, (D) Biplot 
Prediction of the optimal formula and verification of results 
The desire score expresses how close the predicted response value is to the desired response 
value. The desirability values close to 1 indicate closeness to the predicted value. Verification of the 
optimal formula is done by looking at the predictive value consisting of a confidence interval (95% CI) 
and a prediction interval (95% PI). The confidence interval is the value range of the average observed 
results at the 95% confidence level, and the prediction interval is the range of the predicted individual 
values observed at the 95% confidence level (Shiyan et al., 2019; Weissman and Anderson, 2015). 
Tabel 4. The optimum predictive value and verification range 









R1: Weight uniformity 2.29 1.20 2.19 2.39 1.82 2.76 
R2: Moisture content 10.00 5.60 8.81 11.56 5.82 35.56 
R3: Swelling index 23.95 23.66 22.67 25.24 18.29 29.62 
R4: Thickness 3.97 2.25 3.84 4.11 3.35 4.59 
Optimum formula characterization 
Based on the optimal formula testing, it was obtained that the average CV of patch weight was 
0.25 ± 0.003% which fulfilled the requirements of less than 5% (Patel et al., 2012). Moisture content 
9.71 ± 0.54 according to the requirements not more than 10%. The bigger the HPMC and chitosan 
construction formed in the matrix, the greater the moisture content. The swelling index with an 
average of 19.50 ± 4.61%, this indicates that the swelling ability is too small, the release of ibuprofen 
is getting smaller. The optimal matrix thickness is 2.15 ± 0.05 mm. 
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The pH value ensures that the matrix is harmless and does not irritate the skin. The normal pH 
value on the patch is 5-7, while the measurement on the matrix obtained pH 5. The folding resistance 
test aims to determine the folding capacity of the matrix. A patch is said to be good if it has a 
resistance value of more than 300 times. Patches that do not have good resistance will make easily 
brittle and tear. The plasticizer binds to the polymer matrix which can increase the volume of blanks 
between the polymer chains. Therefore, it allows the chain segments to move freely, thereby 
increasing polymer movement, making the matrix more flexible and elastic. 
The uniformity of ibuprofen was 50.81 ± 1.52%, where the results obtained did not meet the 
requirements. This can be caused by the instability of the ibuprofen compound in its manufacture, the 
presence of impurities, the influence of temperature, oxygen, and light. Exposure to oxygen and light 
during the manufacturing process can lead to decreased levels of the compound ibuprofen. Extraction 
of compounds from the matrix is not optimal or even takes longer for the compound to be completely 
extracted from the polymer matrix. The diffusion test graph shows that at the 5th minute the 
penetration starts to increase, and the 30th minute reaches the highest position. At 60, 120, and 180 
minutes showed ibuprofen release (Figure 4A). 
 
Figure 4. (A) In vitro release of ibuprofen of optimum formula, (B) Overlay spectra of 4 run in 
factorial design, (C) FTIR-ATR spectra pattern for each run, (D) FTIR-ATR spectra 
of each component of the matrix 
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Interaction study using Fourier Transform Infrared (FTIR) 
Figure 4 shows the IR spectra pattern of the identified sample. The overlay of the four runs 
(Figure 4B) shows no difference in spectral patterns. Figure 4C is the separation between the overlay 
and steaking between run 1 to run 4. The O-H strain in a wider spectrum of patches characterizes the 
hydroxyl group of the compound ibuprofen. The area of 1500-500 cm-1 in the ibuprofen patch spectra 
is a fingerprint that is still visible in the patch spectra. The transmittance intensity is determined by the 
concentration of the sample used. The intensity is also influenced by the polarity of the functional 
group, the stronger the functional group, the stronger the absorption and the greater the vibration. 
 The presence of OH in the wide patch matrix causes the NH2 of the chitosan to be covered. The 
OH group between pure chitosan and the patch matrix is also known to experience a shift in 
wavenumber (Pratiwi et al., 2019). The addition of PEG 400 and PG plasticizers as enhancers in the 
formula greatly affects the occurrence of the OH shift phenomenon in the spectral pattern. Based on 
this, the matrix system describes the formation of new bonds between chitosan and other constituent 
components. This phenomenon makes the OH bond in the chitosan polymer chain in the patch matrix 
weak. The results of the FTIR-ATR analysis indicate that the physical mixing process in the patch 




The patch produced from chitosan and HPMC has good characteristics, elastic texture, and high 
swelling index so that it will provide a good pharmacological effect. The optimum concentrations of 
chitosan and HPMC needed to produce the optimum formula were chitosan concentrations of 0.5% 
and HPMC of 6%. The release profile of ibuprofen resulted in an appropriate and controlled release at 
60 minutes. The chemometric analysis was successful in providing information in completing the 
evaluation of the design of FFD22. 
ACKNOWLEDGEMENT 
The author is grateful to the Biomaterials and Drug Delivery System (BiDDS) Research Group, 
Departement of Pharmacy STIKES ‘Aisyiyah Palembang. Thanks to Department of Pharmacy, 
Faculty of Mathematics and Natural Sciences, and LPPM Universitas Sriwijaya. 
REFERENCES 
Darusman, F., Ayustine, D. P., Noerman, S., Priani, S. E., & Shalannandia, W. A. (2021). In-vitro 
diffusion study of ibuprofenn-?-cyclodextrin inclusion complex nanogel. Pharmaciana, 11(2), 
213–224. https://doi.org/10.12928/pharmaciana.v11i2.20024 
Kartini, K., Hardianti, D., & Hadiyat, M. A. (2021). Identification of Phyllanthus niruri by FTIR 
spectroscopy with chemometrics. Pharmaciana, 11(2), 251–260. 
https://doi.org/10.12928/pharmaciana.v11i2.15954 
Kulig, D., Zimoch-Korzycka, A., Król, Ż., Oziembłowski, M., & Jarmoluk, A. (2017). Effect of film-
forming alginate/chitosan polyelectrolyte complex on the storage quality of pork. Molecules, 
22(1), 98–114. https://doi.org/10.3390/molecules22010098 
Kumar, S. V., Tarun, P., & Kumar, T. A. (2013). Transdermal drug delivery system for non-steroidal 
anti inflammatory drugs: A review. Indo American Journal of Pharmaceutical Research, 3, 
3588–3605 
Motov, S., Butt, M., Masoudi, A., Palacios, W., Fassassi, C., Drapkin, J., Likourezos, A., Hossain, R., 
Brady, J., Rothberger, N., Flom, P., Zerzan, J., & Marshall, J. (2020). Comparison of Oral 
Ibuprofen and Acetaminophen with Either Analgesic Alone for Pediatric Emergency 
Department Patients with Acute Pain. Journal of Emergency Medicine, 58(5), 725–732. 
https://doi.org/10.1016/j.jemermed.2020.02.010 
Patel, H., Patel, U., Bhimani, B., Daslaniya, D., & Patel, G. (2012). Transdermal drug delivery system 
Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256  
 






as prominent dosage forms for the highly lipophilic drugs. International Journal of 
Pharmaceutical Research and Bio-Science, 1(3), 42–65. 
https://doi.org/10.31638/IJPRS.V1.I1.00018 
Pratiwi, G., Martien, R., & Murwanti, R. (2019). Chitosan nanoparticle as a delivery system for 
polyphenols from meniran extract (Phyllanthus niruri l.): Formulation, optimization, and 
immunomodulatory activity. International Journal of Applied Pharmaceutics, 11(2), 50–58. 
https://doi.org/10.22159/ijap.2019v11i2.29999 
Pratiwi, G., Susanti, S., & Shiyan, S. (2020). Application of factorial design for optimization of pvc-
hpmc polymers in matrix film ibuprofen patch-transdermal drug delivery system. Indonesian 
Journal of Chemometrics and Pharmaceutical Analysis, 1(1), 11–22. 
https://doi.org/10.22146/ijcpa.486 
Ramkanth, S., Jayaprakash, S., & Vimalakannan, T. (2015). Formulation and evaluation of monolithic 
drug in adhesive type patch containing tenoxicam. International Journal of Pharma Sciences 
and Research, 6(04), 654–659 
Romero-Chávez, M. M., Pineda-Urbina, K., Pérez, D. J., Obledo-Benicio, F., Flores-Parra, A., 
Gómez-Sandoval, Z., & Ramos-Organillo, Á. (2018). Organotin(IV) compounds derived from 
ibuprofen and cinnamic acids, an alternative into design of anti-inflammatory by the 
cyclooxygenases (COX-1 and COX-2) pathway. Journal of Organometallic Chemistry, 862, 
58–70. https://doi.org/https://doi.org/10.1016/j.jorganchem.2018.02.049 
Sabati, A. M., Ali, M. A. M., & Ali, B. A. (2017). Formulation and in-vitro evaluation of baclofen 
transdermal patchhes. Asian Journal of Pharmaceutices, 2017(86), 1–28 
Santos, L. F., Correia, I. J., Silva, A. S., & Mano, J. F. (2018). Biomaterials for drug delivery patches. 
European Journal of Pharmaceutical Sciences, 118, 49–66. 
https://doi.org/https://doi.org/10.1016/j.ejps.2018.03.020 
Sarath, C., Shijith, K. V, Vipin, K. V, & Augusthy, A. R. (2013). Formulation and evaluation of 
bisorolol fumarate buccal patchs by using selected polymers. International Jounal of 
Pharmaceutical, Chemical and Biological Sciences, 3(3), 854–860 
Shiyan, S., Arifin, A., Amriani, A., Herlina, & Pratiwi, G. (2020). Immunostimulatory activity of 
ethanol extract from calotropis gigantea l. Flower in rats against salmonella typhimurium 
infection. Research Journal of Pharmacy and Technology, 13(11), 5244–5250. 
https://doi.org/10.5958/0974-360X.2020.00917.8 
Shiyan, S., Hertiani, T., Martien, R., & Nugroho, A. K. (2018). Optimization of a novel kinetic-
assisted infundation for rich-egcg and polyphenols of white tea (Camellia sinensis) using central 
composite design. International Journal of Applied Pharmaceutics, 10(6), 259–267. 
https://doi.org/10.22159/ijap.2018v10i6.29654 
Shiyan, S., Shiyan, S., Martien, R., & Nugroho, A. K. (2019). Optimization and validation of rp-
hplc/uv detection for several compounds simultaneously in semi-purified extract of white tea. 
Rasayan Journal of Chemistry, 12(3), 1098–1109. https://doi.org/10.31788/RJC.2019.1235276 
Singh, A., & Prajapati, U. K. S. S. K. (2017). A review on mucoadhesive buccal patches. International 
Journal of Research and Development in Pharmacy & Life Sciences, 06(04), 2654–2660. 
https://doi.org/10.21276/ijrdpl.2278-0238.2017.6(4).2654-2660 
Tyagi, S., & Goyal, K. (2017). Transdermal drug delivery system: Quality approaches and evaluation. 
Innovat International Journal of Medical and Pharmaceutical Sciences, 2(3) 
Wang, Y., Han, Q., Zhang, H., & Yan, Y. (2020). Evaluation of the binding interactions of p-
acetylaminophenol, aspirin, ibuprofen and aminopyrine with norfloxacin from the view of 
antipyretic and anti-inflammatory. Journal of Molecular Liquids, 312, 113397. 
https://doi.org/https://doi.org/10.1016/j.molliq.2020.113397 
Weissman, S. A., & Anderson, N. G. (2015). Design of experiments (DoE) and process optimization. 
A review of recent publications. Organic Process Research and Development, 19(11), 1605–
1633. https://doi.org/10.1021/op500169m 
 
